From: Tazia Smith To: jeevacation®gmail.com Cm Nay Gu to , Paul Moths , Vahe Stepanian , Vinit Sahni Subject: Re: Biotech Update... (C) Date: Thu, 08 May 2014 18:23:51 +0000 Inline-Images: unnamed: unnamed(1); unnamed(2); unnamed(3); unnamed(4); unnarned(5); unnamed(6): unnamed(7); unnamed(S); unnamed(9) Classification: Confidential Jeffrey - Updatkig you on your biotech basket because most of the names are struggling to rebound from the recent rotational sell-off. exception is GILD which has good valuation support. showed a strong earnings beat. and is back up to -$79.36 (your avg cost is $79.41). FMI reported earnings after the dose yesterday. which were inline but guidance was on the low end. Stock has sold off 15% (down to -$24 currently from from a high of $30 yesterday). Please find your updated PA. below. Included SGMO chart - that company reported a moderately better quarter on Tuesday evening. hence the 3% uptick and several positive reports from the competitors across the Street. As of 5/8/14 2.10 Pm Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 12.17 $ 8.44 $ 608,500.00 422,214.00 186,286.00 smut 2/14/2012 2,095.00 $ 285.28 $ 119.55 $ 597,661.60 250,454.95 $ 347,206.65 FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 24.13 27.51 603,250.00 687,663.50 $ (84,413.50) GILEAD SCIENCES INC Multiple 8,100.00 $ 79.36 $ 79.41 $ 642,816.00 643,204.00 S (388.0D) Total Biotech $ 2,452,227.60 $ 2,003,536.45 $ 448,691.15 ARIAD PHARMACEUTICALS Multiple 16,535.00 S 6.76 17.60 $ 111,776.60 290,997.40 $ (179,220.80) PX_LAST Source: Bloomberg and Pershing LLC as of 518114 /47 084 C 11.80 I 12 J2 L 11.7501 . ':-11 9.23/M 99 Save Line Chart OTEZErlirl I cone.,* 9+, AYT I In -®n®^ . v 1Y 5 nay Only • IMI C Socuntylituey • f yenT 0 4- Track 4 anomie 0. Zoom tom. M Frc,r TaZ4 ScnntAdb